Close Menu

Former Executive of Amgen, Immunex Joins Seattle office of Darby and Darby

Michael Kirschner has joined the Seattle office of Darby and Darby as a principal in the law firm’s chemical & life sciences, and litigation & dispute resolution practice groups, with a specialty in biotechnology.

Kirschner joins Darby & Darby from Hillis Clark Martin & Peterson. He has also served as a vice president of Immunex, and as head of Amgen's Seattle law office after the company acquired Immunex.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.